D-VALNEB 250 MG TABLET | Divalproex Prolonged Release 250 mg
D-VALNEB 250 MG TABLET contains Divalproex Prolonged Release 250 mg, formulated for sustained medication release to support epilepsy, bipolar disorder, and migraine prevention under medical supervision.
D-VALNEB 250 MG TABLET
Product Summary
D-VALNEB 250 MG TABLET is a prescription medicine containing Divalproex Prolonged Release 250 mg, an anticonvulsant and mood-stabilizing medication. Its prolonged-release formulation is designed to provide a steady release of the active ingredient, helping maintain consistent therapeutic levels throughout the day. It is commonly prescribed for the management of epilepsy, bipolar disorder, and the prevention of migraine headaches under the guidance of a qualified healthcare professional.
Product Full Description
D-VALNEB 250 MG TABLET contains Divalproex Prolonged Release 250 mg, a well-established medication used in neurology and psychiatry. The prolonged-release technology allows gradual absorption, helping maintain stable blood concentrations over an extended period. It assists in controlling abnormal electrical activity in the brain associated with seizures and helps stabilize mood in bipolar disorder. It is also prescribed to reduce the frequency of migraine attacks. The medication should always be taken exactly as directed by a healthcare provider to achieve optimal therapeutic outcomes.
Usage Instructions
Follow these instructions while taking D-VALNEB 250 MG TABLET:
Take the tablet exactly as prescribed by your physician.
Swallow the tablet whole with a glass of water.
Do not crush, chew, or split the prolonged-release tablet.
It may be taken with or without food, preferably at the same time each day.
Continue treatment regularly unless your doctor advises otherwise.
Never change the dose without consulting your healthcare provider.
Medicinal Advantages
D-VALNEB 250 MG TABLET offers several clinically recognized therapeutic benefits:
Helps control various types of epileptic seizures.
Assists in stabilizing mood in patients with bipolar disorder.
Reduces the frequency of migraine attacks in suitable patients.
Provides prolonged drug release for more consistent medication levels.
Supports improved long-term disease management when taken regularly.
May reduce fluctuations associated with immediate-release formulations.
Widely recommended in established neurological and psychiatric treatment guidelines under medical supervision.
Mechanism of Action
Divalproex Prolonged Release is converted into valproic acid after absorption. It works by increasing the availability of gamma-aminobutyric acid (GABA), an inhibitory neurotransmitter that helps calm excessive electrical activity in the brain. The medication also influences sodium and calcium channels involved in nerve signal transmission. These combined actions help control seizures, stabilize mood, and reduce the abnormal brain activity associated with migraine development. The prolonged-release formulation ensures gradual drug delivery for sustained therapeutic effects.
Off-Label Uses
Healthcare professionals may prescribe D-VALNEB 250 MG TABLET for certain off-label conditions based on clinical judgment, including:
Management of certain treatment-resistant mood disorders.
Behavioral disturbances associated with selected neurological conditions.
Adjunctive therapy for specific seizure syndromes.
Selected headache disorders when considered appropriate.
Other neurological or psychiatric conditions where valproate therapy may provide clinical benefit.
Off-label use should always occur under specialist supervision.
Expert Advice
For the best therapeutic results:
Take the medicine consistently at the same time every day.
Never stop treatment abruptly without medical advice.
Attend scheduled follow-up appointments for dose evaluation.
Periodic laboratory monitoring may be recommended during long-term therapy.
Inform your doctor about all prescription medicines, supplements, and herbal products you are taking.
Maintain a healthy lifestyle alongside your prescribed treatment plan.
Precautions
1. Liver Function Monitoring
Regular liver function assessment may be recommended because the medication is processed by the liver. Routine monitoring helps ensure safe long-term treatment.
2. Pregnancy Considerations
This medicine requires careful medical evaluation before use during pregnancy due to potential risks. Patients should discuss pregnancy planning and contraception with their healthcare provider.
3. Do Not Alter the Tablet
Do not crush, chew, or split the prolonged-release tablet, as this may interfere with the controlled-release mechanism and affect medication performance.
4. Regular Medical Monitoring
Routine blood tests may be advised to monitor treatment response and ensure the medication remains appropriate throughout therapy.
5. Drug Interactions
Inform your healthcare provider about all medicines you use, including over-the-counter medications and supplements, as interactions may require dosage adjustments.
Storage Conditions
Store below 25°C in a cool, dry place.
Protect from excessive heat, moisture, and direct sunlight.
Keep the tablets in their original packaging until use.
Keep out of the reach of children and pets.
Do not use after the expiry date mentioned on the package.
Frequently Asked Questions (FAQs)
1. What is D-VALNEB 250 MG TABLET used for?
It is prescribed for the management of epilepsy, bipolar disorder, and prevention of migraine headaches under medical supervision.
2. What does the prolonged-release formulation mean?
It means the medicine is released gradually over time, helping maintain more consistent drug levels in the body.
3. Can I take D-VAINEB 250 MG TABLET with food?
Yes. It may be taken with or without food, following your doctor's instructions.
4. Can I break or crush the tablet?
No. Swallow the tablet whole to preserve its prolonged-release properties.
5. How long does treatment usually continue?
Treatment duration depends on your medical condition and your healthcare provider's assessment.
6. What should I do if I miss a dose?
Take the missed dose as soon as you remember unless it is nearly time for your next scheduled dose. Do not take two doses together.
7. Is regular monitoring necessary during treatment?
Yes. Your physician may recommend periodic blood tests and clinical evaluations during long-term therapy.
8. Can D-VALNEB 250 MG TABLET be taken with other medicines?
It can interact with certain medications. Always inform your healthcare provider about every medicine or supplement you are taking before starting treatment.
Suggested Product Tags
D-VALNEB-250 MG TABLET
DIVAPROEX PROLONGED RELEASE TABLET 250 MG
Divaproex Sodium PR Tablet
Divaproex 250 mg
Prolonged Release Tablet
Anticonvulsant Medicine
Epilepsy Treatment
Bipolar Disorder Medication
Migraine Prevention
Mood Stabilizer
Neurology Medicine
Prescription Medicine
Seizure Control
CNS Medication
Mental Health Medicine
Oral Prolonged Release Tablet
